NeuBase Therapeutics, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
NeuBase Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q3 2023.
  • NeuBase Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2023 was $992K, a 984% increase year-over-year.
  • NeuBase Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2023 was $1.54M.
  • NeuBase Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$458K, a 140% decline from 2021.
  • NeuBase Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $1.16M.
  • NeuBase Therapeutics, Inc. annual Nonoperating Income (Expense) for 2018 was $667K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $1.54M $992K +$901K +984% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $635K $241K +$372K Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $263K $71.2K +$65.8K +1229% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $197K $231K +$655K Oct 1, 2022 Dec 31, 2022 10-QT 2023-06-05
Q3 2022 -$458K $91.5K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$131K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $5.35K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$424K Oct 1, 2021 Dec 31, 2021 10-QT 2023-06-05
Q2 2019 $37.9K $3.96K -$617K -99.4% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $655K $9.82K +$10.8K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-15
Q4 2018 $644K $8.76K -$22.6K -72.1% Oct 1, 2018 Dec 31, 2018 10-Q 2019-02-14
Q3 2018 $667K $15.4K +$1.42K +10.2% Jul 1, 2018 Sep 30, 2018 10-K 2019-01-03
Q2 2018 $666K $621K +$666K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$610 -$1.01K -$797 -383% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $187 $31.4K +$31.1K +11071% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q3 2017 -$30.9K $13.9K -$159K -91.9% Jul 1, 2017 Sep 30, 2017 10-K 2019-01-03
Q2 2017 $128K -$44.9K +$56.2K +55.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $72.1K -$208* -$1.31M -100% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $1.38M $281* +$2.55M Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-14
Q3 2016 -$1.17M $173K +$286K Jul 1, 2016 Sep 30, 2016 10-K 2017-12-15
Q2 2016 -$1.46M -$101K -$90K -806% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$1.37M $1.31M -$2.09M -61.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 $728K -$2.55M -$1.88M -279% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-14
Q3 2015 $2.61M -$113K -$101K -857% Jul 1, 2015 Sep 30, 2015 10-K 2016-12-22
Q2 2015 $2.71M -$11.2K -$15.5K -358% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $2.72M $3.41M +$3.41M +2579855% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$682K -$674K -$674K -156000% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 -$7.74K -$11.8K -$10.8K -1077% Jul 1, 2014 Sep 30, 2014 10-K 2016-12-22
Q2 2014 $3.03K $4.33K +$7.18K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$4.16K $132* -$376K -100% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $372K -$432 +$1.4M +100% Oct 1, 2013 Dec 31, 2013 10-Q/A 2015-02-10
Q3 2013 -$1.03M -$1K -$1.32M -100% Jul 1, 2013 Sep 30, 2013 10-K 2015-12-14
Q2 2013 $284K -$2.86K -$177K -102% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-18
Q1 2013 $461K $376K +$881K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q4 2012 -$420K -$1.4M -$2.25M -266% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 $1.83M $1.31M +$2.3M Jul 1, 2012 Sep 30, 2012 10-K 2014-12-22
Q2 2012 -$466K $174K +$3.01M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-13
Q1 2012 -$3.48M -$505K -$564K -956% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q4 2011 -$2.91M $848K +$946K Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-19
Q3 2011 -$3.86M -$983K Jul 1, 2011 Sep 30, 2011 10-K 2013-01-09
Q2 2011 -$2.84M -$3.01M -1693% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 $59K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q4 2010 -$98.4K Oct 1, 2010 Dec 31, 2010 10-Q/A 2012-02-14
Q2 2010 $178K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.